These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 21418073

  • 1. Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome?
    Steele D, Keltner NL, McGuiness TM.
    Perspect Psychiatr Care; 2011 Jan; 47(1):58-62. PubMed ID: 21418073
    [No Abstract] [Full Text] [Related]

  • 2. Serotonin syndrome and atypical antipsychotics.
    Duggal HS, Fetchko J.
    Am J Psychiatry; 2002 Apr; 159(4):672-3. PubMed ID: 11925312
    [No Abstract] [Full Text] [Related]

  • 3. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA, Zivot J, Ariano RE.
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [Abstract] [Full Text] [Related]

  • 4. [Neuroleptic malignant syndrome].
    Bryois C, Bondolfi G.
    Rev Med Suisse Romande; 1996 Sep; 116(9):713-7. PubMed ID: 8966472
    [No Abstract] [Full Text] [Related]

  • 5. [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
    Real Rodríguez B, Ruibal JL, Grande Rodríguez S, Sueiro Pita B.
    An Esp Pediatr; 1996 Jan; 44(1):60-2. PubMed ID: 8849063
    [No Abstract] [Full Text] [Related]

  • 6. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death.
    Kline SS, Mauro LS, Scala-Barnett DM, Zick D.
    Clin Pharm; 1989 Jul; 8(7):510-4. PubMed ID: 2568897
    [No Abstract] [Full Text] [Related]

  • 7. Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
    Dan A, Bharadwaj R, Grover S.
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404
    [No Abstract] [Full Text] [Related]

  • 8. The evaluation and management of patients with neuroleptic malignant syndrome.
    Bhanushali MJ, Tuite PJ.
    Neurol Clin; 2004 May; 22(2):389-411. PubMed ID: 15062519
    [Abstract] [Full Text] [Related]

  • 9. Serotonin syndrome overlapping with neuroleptic malignant syndrome: A case report and approaches for differentially diagnosing the two syndromes.
    Nisijima K.
    Asian J Psychiatr; 2015 Dec; 18():100-1. PubMed ID: 26506919
    [Abstract] [Full Text] [Related]

  • 10. Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics.
    Hatch CD, Lund BC, Perry PJ.
    Pharmacotherapy; 2001 Aug; 21(8):1003-6. PubMed ID: 11718487
    [Abstract] [Full Text] [Related]

  • 11. [Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis].
    König F, Löble M, Wolfersdorf M.
    Nervenarzt; 1996 May; 67(5):407-12. PubMed ID: 9005353
    [Abstract] [Full Text] [Related]

  • 12. Serotonin syndrome and other serotonergic disorders.
    Ener RA, Meglathery SB, Van Decker WA, Gallagher RM.
    Pain Med; 2003 Mar; 4(1):63-74. PubMed ID: 12873279
    [Abstract] [Full Text] [Related]

  • 13. Neuroleptic malignant syndrome and catatonia. A report of three cases.
    Raja M, Altavista MC, Cavallari S, Lubich L.
    Eur Arch Psychiatry Clin Neurosci; 1994 Mar; 243(6):299-303. PubMed ID: 7913834
    [Abstract] [Full Text] [Related]

  • 14. Case reports of neuroleptic malignant syndrome in context of quetiapine use.
    Detweiler MB, Sullivan K, Sharma TR, Kim KY, Detweiler JG.
    Psychiatr Q; 2013 Dec; 84(4):523-41. PubMed ID: 23686527
    [Abstract] [Full Text] [Related]

  • 15. Atypical neuroleptic malignant syndrome with quetiapine: a case report and review of the literature.
    El-Gaaly S, St John P, Dunsmore S, Bolton JM.
    J Clin Psychopharmacol; 2009 Oct; 29(5):497-9. PubMed ID: 19745653
    [No Abstract] [Full Text] [Related]

  • 16. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A, Bodini P, Dizioli P, Chiodelli G, Guarneri M, Boldori L.
    Minerva Med; 1996 Oct; 87(1-2):45-51. PubMed ID: 8610025
    [Abstract] [Full Text] [Related]

  • 17. Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome.
    Eiser AR, Neff MS, Slifkin RF.
    Arch Intern Med; 1982 Mar; 142(3):601-3. PubMed ID: 6121542
    [Abstract] [Full Text] [Related]

  • 18. [Neuroleptic malignant syndrome].
    Charra B, Nejmi H, Hachimi A, Benslama A, Motaouakkil S.
    Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
    [No Abstract] [Full Text] [Related]

  • 19. Mirtazapine: unable to induce serotonin toxicity?
    Gillman PK.
    Clin Neuropharmacol; 2003 May; 26(6):288-9; author reply 289-90. PubMed ID: 14646604
    [No Abstract] [Full Text] [Related]

  • 20. Adverse reactions to mirtazapine are unlikely to be serotonin toxicity.
    Isbister GK, Whyte IM.
    Clin Neuropharmacol; 2003 May; 26(6):287-8; author reply 289-90. PubMed ID: 14646603
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.